β¨ Medicines Classification
NEW ZEALAND GAZETTE
No. 96
prevention of travel sickness and sold at a transport terminal or aboard a ship or plane
Emetine; and its salts; except in ipecacuanha and extracts and tinctures of ipecacuanha, and in medicines containing more than 0.05% of emetine
Ether; when used as a vehicle for a topical dose form
Fluorescein
Fluorides; in medicines for internal use containing 2.2 milligrams or less of fluoride per dosage unit; in medicines for external use containing fluoride in proportion equivalent to more than 0.1% of elemental fluorine
Folic acid; in medicines containing more than 500 mcg of folic acid per recommended daily dose
Glucagon
Guaiphenesin; in medicines containing more than 2% of guaiphenesin
Hetastarch
Hydrocortisone; and hydrocortisone acetate; in medicines for dermatological use containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of not more than 15 grams or 15 millilitres per container
Hydroquinone; in medicines containing more than 2% of hydroquinone
Ibuprofen; for external use
Idoxuridine; in medicines containing 0.5% or less of idoxuridine for dermatological use
Indomethacin; in medicines for external use containing 1% or less of indomethacin
Ipecacuanha
Jaborandi; alkaloids of; and their salts; in medicines containing 0.5% or more of the alkaloids of jaborandi
Ketoconazole; for dermatological use
Ketoprofen; and its salts; in medicines for external use
Lignocaine; and its salts; in medicines for external use containing more than 2% of lignocaine
Lobelia; alkaloids of; and their salts
Loratadine
Meclozine; and its salts; except in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane
Mefenamic acid; and its salts; in solid dose forms of 250 mg or less and in a pack containing not more than 20 tablets or capsules for the treatment of dysmenorrhoea
Mequitazine
Naproxen; and its salts; in solid dose forms containing the equivalent of 250 mg or less of naproxen per dose form, when in a pack containing not more than 20 tablets or capsules and sold for the treatment of dysmenorrhoea
Nicotine; in medicines for transdermal use
Noradrenaline; and its salts
Nystatin; in medicines for dermatological use
Oxerutins
Oxiconazole nitrate
Oxymetazoline; and its salts; for nasal use except when sold at an airport
Paracetamol; except where specified elsewhere in this notice
Pentastarch
Phenazone
Phenylephrine; for nasal use except when sold at an airport
Piroxicam; in medicines for external use containing 1% or less of piroxicam
Polygeline
Potassium chloride; except in medicines for oral rehydration therapy; except for use in haemodialysis concentrates and peritoneal dialysis solutions
Potassium citrate; except in medicines for oral rehydration therapy
Potassium perchlorate
Pramocaine; for external use in medicines containing more than 2%
Pregnancy test kits
Prilocaine; for external use in medicines containing more than 2%
Promethazine; and its salts; except promethazine theoclate in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane
Salicylic acid; and its salts; in medicines for external use containing more than 12.5% of salicylic acid
Selenium; and compounds of selenium; in medicines for external use containing more than 2.5% of selenium; and in medicines for internal use where the recommended daily dose exceeds 150 micrograms of selenium
Sennosides
Sodium cromoglycate; for nasal and ophthalmological use
Sulphadiazine; and its salts; in medicines for external use when in pack sizes containing 50 grams or less
Terbinafine; for external use
Thiomersal
Xylometazoline; and its salts; except for nasal use when sold at an airport
Yohimbe; alkaloids of; and their salts
Fourth Schedule
General Sale Medicines
Aconite; alkaloids of; and their salts; in medicines for external use containing less than 0.02% of the alkaloids of aconite
Adrenal extract; in dermatological medicines containing 0.02% or less of ketosteroids
Aescin; in medicines for external use
Aloes; in medicines for external use
Aluminium; and its salts; in medicines for external use
Aspirin; in enteric coated forms containing 300 mg or less per dose form
Barium sulphate
Benzocaine; for external use in medicines containing 2% or less; in throat lozenges containing 30 milligrams or less per dose form
Benzoyl peroxide; in medicines for external use containing 5% or less of benzoyl peroxide
Benzyl benzoate; in medicines containing 2.5% or less of benzyl benzoate
Beta carotene; in medicines containing 18 mg or less per recommended daily dose
Berberine
Bioallethrin; in medicines for external use
Butoxyethyl nicotinate
Cade oil; in medicines for external use
Calcium glucono-galacto-gluconate; except for parenteral use
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1995, No 96
NZLII —
NZ Gazette 1995, No 96
β¨ LLM interpretation of page content
π₯
Classification of Medicines under the Medicines Act 1981
(continued from previous page)
π₯ Health & Social WelfareMedicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines, General Sale Medicines, Classification